Business and Finance

Home » Business and Finance

Celgene’s Acquisition of Juno Therapeutics Puts the Company in a Good Position to be a Frontrunner in the CAR-T space

Celgene’s recent announcement of the acquisition of Juno Therapeutics has put the company in a good position to be a frontrunner in the chimeric antigen receptor- T cell (CAR-T) space. Celgene stands to benefit from Juno’s expertise and ongoing work into addressing concerns surrounding CAR-T, according to GlobalData, a leading data and analytics company. In [...]

US Pharma Industry Holds to Price-Cap Pledge

As part of a growing tradition, the new year coincides with a hike in US drug prices, with more than 30 drugs seeing an increase in price. However, after receiving continued criticism from both the public and politicians, it appears that the industry is sticking within a 10% self-imposed price-hike limit, observes GlobalData, a leading [...]

PCI Pharma Services Announces Intent to Acquire Australia-Based Pharmaceutical Packaging Professionals

Leading pharmaceutical outsourcing services provider, PCI Pharma Services (PCI), has announced its intent to acquire Australia-based Pharmaceutical Packaging Professionals (PPP). The acquisition of PPP, a leading provider of clinical trial manufacturing, packaging, storage and distribution services, establishes a presence for PCI in Australia, viewed as pivotal to continued growth and expansion in the Asia-Pacific region. [...]

Digital Skills and Access to Finance Highlighted as Top Two Industry 4.0 Challenges

Siemens Financial Services (SFS) has released a new research paper that investigates the key challenges facing manufacturers across the globe as they move to implement Industry 4.0. A digitalised, automated, Industry 4.0 world offers the ability to digitally link people, machinery and systems. For manufacturers, this provides a number of benefits such as improved efficiency, [...]

Idifarma Announces Serialisation Investment 12 Months Ahead of EU Deadline

Spanish contract development and manufacturing organisation (CDMO) Idifarma has announced its plans to meet forthcoming EU serialisation regulations with a €200,000 investment. The investment will see the installation of the Antares Vision Print&Check EVO-TE carton serialisation station at its EU-GMP approved plant in Pamplona, Spain, and comes ahead of the EU Falsified Medicines Directive’s (EU [...]

EVER Pharma Adopts Veeva OpenData and Veeva CRM to Transform Customer Engagement

Veeva Systems has announced that specialty pharmaceutical company EVER Pharma has adopted Veeva OpenData and Veeva CRM to empower its growing team in Poland with the accurate customer data necessary to drive smarter, tailored engagement with healthcare professionals (HCPs). Timing was critical for EVER Pharma as the company prepared its field team for two upcoming product [...]

Vetter Introduces South Korea’s Pharma and Biotech Community to Meet Company Management

Vetter customer event, South Korea office In an event at its new branch office attended by key customers, business associates and local journalists, Vetter’s senior management representatives presented the company’s service portfolio along with its growth strategy for South Korea and the Asia Pacific (APAC) region. In addition, attendees were introduced to Mr [...]

Corporate Heavyweights Tackle Healthcare

Three of the most respected corporations in America announced plans this week to start a new company to tackle rising healthcare costs. The three companies – Amazon, Berkshire Hathaway and JP Morgan Chase – are dominant in their respect business sectors and their chief executives – Jeff Bezos, Warren Buffett and Jamie Dimon, respectively — [...]

Cobra Biologics and Symbiosis Awarded £1.9 Million Innovate UK Grant

Cobra Biologics (Cobra), an international contract development and manufacturing organisation (CDMO) of biologics and pharmaceuticals, and Symbiosis Pharmaceutical Services (Symbiosis), a contract manufacturing organisation (CMO) specialising in sterile fill finish, have been awarded a 16-month collaborative grant of £1.9 million from Innovate UK. The grant will position the partner companies as globally recognised centres of [...]

Porton Pharma Solutions and BioDuro Announce a Strategic Alliance and Marketing Agreement

Porton Pharma Solutions, a leading provider of custom, cross lifecycle active pharmaceutical ingredient (API) development and cGMP manufacturing services to the global drug industry, and BioDuro LLC, a leading global life sciences contract research, development and manufacturing organisation, have announced a strategic alliance and comarketing partnership. Under this agreement, Porton will incorporate BioDuro’s extensive array of [...]